Eric Benevich - Nov 2, 2020 Form 4/A - Amendment Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Chief Commercial Officer
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Stock symbol
NBIX
Transactions as of
Nov 2, 2020
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/11/2023, 04:55 PM
Date Of Original Report
Nov 4, 2020
Previous filing
May 11, 2023
Next filing
Aug 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NBIX Common Stock 15.8K Nov 2, 2020 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The initial Form 4 filed on 11/04/2020 inadvertently omitted 155 shares that the reporting person owned directly associated with the purchase of such shares on August 31, 2020 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.